Early administration of ritonavir-boosted lopinavir could prevent severe COVID-19

J Infect. 2021 Jan;82(1):159-198. doi: 10.1016/j.jinf.2020.05.039. Epub 2020 May 27.
No abstract available

Keywords: Covid-19; Lopinavir; Protease inhibitor; Sars-cov-2; Virology; pharmacology.

Publication types

  • Letter
  • Comment

MeSH terms

  • Antiviral Agents* / therapeutic use
  • COVID-19*
  • Disease Outbreaks
  • Humans
  • Lopinavir / therapeutic use
  • Pneumonia* / drug therapy
  • Prospective Studies
  • Ritonavir / therapeutic use
  • SARS-CoV-2
  • Severe Acute Respiratory Syndrome*
  • Viral Load

Substances

  • Antiviral Agents
  • Lopinavir
  • Ritonavir